Literature DB >> 30523785

The Hippo Pathway Prevents YAP/TAZ-Driven Hypertranscription and Controls Neural Progenitor Number.

Alfonso Lavado1, Jun Young Park1, Joshua Paré1, David Finkelstein2, Haitao Pan3, Beisi Xu2, Yiping Fan2, Ram Parikshan Kumar1, Geoffrey Neale4, Young Don Kwak5, Peter J McKinnon5, Randy L Johnson6, Xinwei Cao7.   

Abstract

The Hippo pathway controls the activity of YAP/TAZ transcriptional coactivators through a kinase cascade. Despite the critical role of this pathway in tissue growth and tumorigenesis, it remains unclear how YAP/TAZ-mediated transcription drives proliferation. By analyzing the effects of inactivating LATS1/2 kinases, the direct upstream inhibitors of YAP/TAZ, on mouse brain development and applying cell-number-normalized transcriptome analyses, we discovered that YAP/TAZ activation causes a global increase in transcription activity, known as hypertranscription, and upregulates many genes associated with cell growth and proliferation. In contrast, conventional read-depth-normalized RNA-sequencing analysis failed to detect the scope of the transcriptome shift and missed most relevant gene ontologies. Following a transient increase in proliferation, however, hypertranscription in neural progenitors triggers replication stress, DNA damage, and p53 activation, resulting in massive apoptosis. Our findings reveal a significant impact of YAP/TAZ activation on global transcription activity and have important implications for understanding YAP/TAZ function.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CNN RNA-seq; ERCC normalization; Hippo signaling; Myc; NanoString; TEAD; neural stem cells; neurosphere; radial glia; transcriptional amplification

Mesh:

Substances:

Year:  2018        PMID: 30523785      PMCID: PMC6296252          DOI: 10.1016/j.devcel.2018.09.021

Source DB:  PubMed          Journal:  Dev Cell        ISSN: 1534-5807            Impact factor:   12.270


  67 in total

1.  In vivo structure-function analysis of human Dicer reveals directional processing of precursor miRNAs.

Authors:  Allan M Gurtan; Victoria Lu; Arjun Bhutkar; Phillip A Sharp
Journal:  RNA       Date:  2012-04-30       Impact factor: 4.942

2.  Direct multiplexed measurement of gene expression with color-coded probe pairs.

Authors:  Gary K Geiss; Roger E Bumgarner; Brian Birditt; Timothy Dahl; Naeem Dowidar; Dwayne L Dunaway; H Perry Fell; Sean Ferree; Renee D George; Tammy Grogan; Jeffrey J James; Malini Maysuria; Jeffrey D Mitton; Paola Oliveri; Jennifer L Osborn; Tao Peng; Amber L Ratcliffe; Philippa J Webster; Eric H Davidson; Leroy Hood; Krassen Dimitrov
Journal:  Nat Biotechnol       Date:  2008-02-17       Impact factor: 54.908

Review 3.  The regulation of mRNA stability in mammalian cells: 2.0.

Authors:  Xiangyue Wu; Gary Brewer
Journal:  Gene       Date:  2012-03-16       Impact factor: 3.688

Review 4.  Hippo signalling in the G2/M cell cycle phase: lessons learned from the yeast MEN and SIN pathways.

Authors:  Alexander Hergovich; Brian A Hemmings
Journal:  Semin Cell Dev Biol       Date:  2012-04-15       Impact factor: 7.727

5.  Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size.

Authors:  Mei Xin; Yuri Kim; Lillian B Sutherland; Xiaoxia Qi; John McAnally; Robert J Schwartz; James A Richardson; Rhonda Bassel-Duby; Eric N Olson
Journal:  Sci Signal       Date:  2011-10-25       Impact factor: 8.192

6.  Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.

Authors:  Bin Zhao; Xiaomu Wei; Weiquan Li; Ryan S Udan; Qian Yang; Joungmok Kim; Joe Xie; Tsuneo Ikenoue; Jindan Yu; Li Li; Pan Zheng; Keqiang Ye; Arul Chinnaiyan; Georg Halder; Zhi-Chun Lai; Kun-Liang Guan
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

7.  Visualizing spatiotemporal dynamics of multicellular cell-cycle progression.

Authors:  Asako Sakaue-Sawano; Hiroshi Kurokawa; Toshifumi Morimura; Aki Hanyu; Hiroshi Hama; Hatsuki Osawa; Saori Kashiwagi; Kiyoko Fukami; Takaki Miyata; Hiroyuki Miyoshi; Takeshi Imamura; Masaharu Ogawa; Hisao Masai; Atsushi Miyawaki
Journal:  Cell       Date:  2008-02-08       Impact factor: 41.582

8.  Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth.

Authors:  Francesca Zanconato; Mattia Forcato; Giusy Battilana; Luca Azzolin; Erika Quaranta; Beatrice Bodega; Antonio Rosato; Silvio Bicciato; Michelangelo Cordenonsi; Stefano Piccolo
Journal:  Nat Cell Biol       Date:  2015-08-10       Impact factor: 28.824

Review 9.  The DNA fibre technique - tracking helicases at work.

Authors:  Jadwiga Nieminuszczy; Rebekka A Schwab; Wojciech Niedzwiedz
Journal:  Methods       Date:  2016-04-18       Impact factor: 3.608

10.  β-Catenin destruction complex-independent regulation of Hippo-YAP signaling by APC in intestinal tumorigenesis.

Authors:  Jing Cai; Anirban Maitra; Robert A Anders; Makoto M Taketo; Duojia Pan
Journal:  Genes Dev       Date:  2015-07-20       Impact factor: 11.361

View more
  31 in total

1.  YAP/TAZ maintain the proliferative capacity and structural organization of radial glial cells during brain development.

Authors:  Alfonso Lavado; Ruchika Gangwar; Joshua Paré; Shibiao Wan; Yiping Fan; Xinwei Cao
Journal:  Dev Biol       Date:  2021-08-19       Impact factor: 3.582

2.  Inhibition of Karyopherin β1-Mediated Nuclear Import Disrupts Oncogenic Lineage-Defining Transcription Factor Activity in Small Cell Lung Cancer.

Authors:  Demetra P Kelenis; Kathia E Rodarte; Rahul K Kollipara; Karine Pozo; Shreoshi Pal Choudhuri; Kyle B Spainhower; Sarah J Wait; Victor Stastny; Trudy G Oliver; Jane E Johnson
Journal:  Cancer Res       Date:  2022-09-02       Impact factor: 13.312

3.  YAP1 is involved in replenishment of granule cell precursors following injury to the neonatal cerebellum.

Authors:  Zhaohui Yang; Alexandra L Joyner
Journal:  Dev Biol       Date:  2019-07-31       Impact factor: 3.582

4.  TAZ functions as a tumor suppressor in multiple myeloma by downregulating MYC.

Authors:  Stacy Grieve; Gabriel Wajnberg; Miranda Lees; Simi Chacko; Jackson Weir; Nicolas Crapoulet; Tony Reiman
Journal:  Blood Adv       Date:  2019-11-26

5.  TAZ Represses the Neuronal Commitment of Neural Stem Cells.

Authors:  Natalia Robledinos-Antón; Maribel Escoll; Kun-Liang Guan; Antonio Cuadrado
Journal:  Cells       Date:  2020-10-02       Impact factor: 6.600

6.  YAP-dependent proliferation by a small molecule targeting annexin A2.

Authors:  Sophia Z Shalhout; Peng-Yu Yang; Edyta M Grzelak; Kayla Nutsch; Sida Shao; Claudio Zambaldo; Jonathan Iaconelli; Lara Ibrahim; Caroline Stanton; Stormi R Chadwick; Emily Chen; Michael DeRan; Sijia Li; Mitchell Hull; Xu Wu; Arnab K Chatterjee; Weijun Shen; Fernando D Camargo; Peter G Schultz; Michael J Bollong
Journal:  Nat Chem Biol       Date:  2021-03-15       Impact factor: 15.040

Review 7.  The Act of Controlling Adult Stem Cell Dynamics: Insights from Animal Models.

Authors:  Meera Krishnan; Sahil Kumar; Luis Johnson Kangale; Eric Ghigo; Prasad Abnave
Journal:  Biomolecules       Date:  2021-04-30

8.  Transcriptional Modulation of the Hippo Signaling Pathway by Drugs Used to Treat Bipolar Disorder and Schizophrenia.

Authors:  Bruna Panizzutti; Chiara C Bortolasci; Briana Spolding; Srisaiyini Kidnapillai; Timothy Connor; Mark F Richardson; Trang T T Truong; Zoe S J Liu; Gerwyn Morris; Laura Gray; Jee Hyun Kim; Olivia M Dean; Michael Berk; Ken Walder
Journal:  Int J Mol Sci       Date:  2021-07-02       Impact factor: 5.923

9.  SMC5/6 is required for replication fork stability and faithful chromosome segregation during neurogenesis.

Authors:  Alisa Atkins; Michelle J Xu; Maggie Li; Nathaniel P Rogers; Marina V Pryzhkova; Philip W Jordan
Journal:  Elife       Date:  2020-11-17       Impact factor: 8.140

10.  YAP/TAZ Transcriptional Coactivators Create Therapeutic Vulnerability to Verteporfin in EGFR-mutant Glioblastoma.

Authors:  Krishanthan Vigneswaran; Nathaniel H Boyd; Se-Yeong Oh; Shoeb Lallani; Andrew Boucher; Stewart G Neill; Jeffrey J Olson; Renee D Read
Journal:  Clin Cancer Res       Date:  2020-11-10       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.